×

Stocks GlaxoSmithKline PLC

  • graphic_word_ofthe_street.jpg

    Concerns that the recent outbreak of swine flu could reach pandemic proportions dragged down the Dow and S&P Monday with investors hammering airlines, hotels and more.

  • Stocks bounced back from a swine flu-induced drop Monday as traders scooped up shares of drug makers and pharmacies.

  • flu_outbreak2.jpg

    The threat of a widespread swine flu outbreak weighed on the markets Monday, and for good reason: Even if the virus is contained, it's still likely to put a crimp on spending for a wide array of goods.

  • graphic_fast_money.jpg

    Concerns that the swine flu could reach pandemic proportions sent money moving. Who wins and who loses?

  • Swine Flu: global pandemic or paranoia? President Obama said the health emergency declaration was merely a prudent measure. But many pharmaceutical stocks were sharply higher Monday in reaction to flu outbreaks — and the gains seemed to ripple through the sector.

  • As author of World Event Trading, I did an entire section on infectious diseases from the 1918 Spanish Flu to Bird Flu. The recent outbreak of Swine Flu is generating headlines and concerns globally......Critical point: fear of the disease is the biggest driver of behavior and societal changes due to the outbreak.

  • Financials continue to lead the weakness today on the heels of Bank of America’s earnings report. In late-morning trading, B of A and Citigroup are now down 15 percent each, while many other regional banks are 11 to 15 percent lower.

  • webxtra_thumb.jpg

    In this Web Extra, Pete Najarian talks Pharma takeovers. What's on his radar?

  • Pills

    An estimated 20 million or so Americans have the disease, which many experts call an epidemic. It costs this country tens of billions of dollars a year to deal with it. And several biopharma and monitoring device companies are racing to grab a bigger piece of this fast-growing, sugar-free pie.

  • Breakthrough diabetes treatments may be on the horizon. What companies stand to win?

  • A number of takeover rumors have been making the rounds, an encouraging sign that capitalistic optimism is returning to the markets.

  • OptionMonster Jon Najarian reveals where he's spotted some unusually bullish action.

  • webxtra_thumb.jpg

    The Pit Boss is seeing explosive options action in a drug stock. Find out which one!

  • graphic_fast_money.jpg

    Both Pete and Jon Najarian are seeing some unusual options action. What do they make of it?

  • Plus, Cramer discusses credit-card and drug stocks, as well as the housing bottom.

  • graphic_fast_money.jpg

    The OptionMonster is seeing unusual action in two stocks. What does he make of it?

  • My first week on Twitter has gone pretty well. Despite some Twitter trouble (or should that be twubble?) with website capacity, I've picked up more than 75 followers already.

  • alli_logo.jpg

    Normally, the folks at GlaxoSmithKline keep us tightly in the loop when there's news. So, I'm a bit surprised that it took a "tweet" on Twitter this morning to learn that four days ago the company put out a press release that has "Pharma's Market" written all over it.

  • Japan and Januvia. No, it's not a country—not even a fictional one—even though it sounds like "Genovia" in "The Princess Diaries." It's a diabetes drug from Merck.

  • JOBLESS_noTEXT.jpg

    The number of job cuts continued to soar in February 2009, reflecting the worsening US recession.